Veterinary Orodispersible Tablets Market Report 2026

Veterinary Orodispersible Tablets Market Overview

• Veterinary Orodispersible Tablets market size has reached to $1.12 billion in 2025 • Expected to grow to $1.65 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: The Expanding Companion-Animal Healthcare Spending By Pet Owners Is Fueling The Growth Of The Market Due To Increasing Investment In Pet Wellness And Preventive Care • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Orodispersible Tablets Market?

Veterinary orodispersible tablets are rapidly dissolving oral formulations for animals that disintegrate in the mouth without requiring water, making administration simple and stress-free. They enhance treatment compliance by easing dosing and ensuring precise medication delivery and are especially suitable for companion animals like dogs and cats. Additionally, veterinary orodispersible tablets offer greater convenience for pet owners and can contribute to a quicker therapeutic effect in certain treatments. The main product types of veterinary orodispersible tablets include analgesics, antibiotics, anthelmintics, antipyretics, and other product types. Analgesics refer to fast-dissolving veterinary tablet formulations designed to provide rapid therapeutic action through oral dispersion without water intake. The formulation framework includes animal types such as companion animals, livestock animals, and other animal types. The key applications of infectious diseases, pain management, gastrointestinal disorders, and other applications, while the end-use includes veterinary clinics, veterinary hospitals, research institutes, and other end users.

What Is The Veterinary Orodispersible Tablets Market Growth Forecast?

The veterinary orodispersible tablets market size is expected to see strong growth in the next few years.It will grow to $1.65 billion by 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to rising demand for pet-friendly medication formats, increasing adoption of precision drug delivery systems, growth in companion animal healthcare expenditure, advancement in veterinary pharmaceutical formulation technologies, expanding focus on treatment compliance and ease of administration.Major trends in the forecast period include development of taste-masked formulation technologies to improve palatability of veterinary orodispersible tablets, increasing adoption of fast-disintegrating polymer matrices for enhanced drug dissolution in animal oral delivery, rising use of precision-compounded low-dose orodispersible tablets for companion animal therapies, growing integration of advanced excipient engineering to improve stability and disintegration speed in veterinary tablets, expansion of stress-free pet medication delivery systems to improve treatment adherence in animals.

Global Veterinary Orodispersible Tablets Market Segmentation

1) By Product Type: Analgesics, Antibiotics, Anthelmintics, Antipyretics, Other Product Types 2) By Animal Type: Companion Animals, Livestock Animals, Other Animal Types 3) By Application: Infectious Diseases, Pain Management, Gastrointestinal Disorders, Other Applications 4) By End User: Veterinary Clinics, Veterinary Hospitals, Research Institutes, Other End Users Subsegments: 1) By Analgesics: Non Steroidal Anti Inflammatory Analgesics, Opioid Analgesics, Local Analgesics, Combination Analgesics, Herbal Analgesics 2) By Antibiotics: Beta Lactam Antibiotics, Tetracycline Antibiotics, Aminoglycoside Antibiotics, Macrolide Antibiotics, Fluoroquinolone Antibiotics 3) By Anthelmintics: Benzimidazole Anthelmintics, Macrocyclic Lactone Anthelmintics, Imidazothiazole Anthelmintics, Praziquantel Based Anthelmintics, Combination Anthelmintics 4) By Antipyretics: Non Steroidal Anti Inflammatory Antipyretics, Acetaminophen Based Antipyretics, Aspirin Based Antipyretics, Herbal Antipyretics, Combination Antipyretics 5) By Other Product Types: Antihistamines, Vitamins And Supplements, Probiotics, Cardiovascular Agents, Respiratory Agents

What Are The Drivers Of The Veterinary Orodispersible Tablets Market?

The expanding companion-animal healthcare spending by pet owners is expected to propel the growth of veterinary orodispersible tablets forward.Companion-animal healthcare spending by pet owners refers to the total expenditure by individuals on veterinary services, preventive care, treatments, and related health products for their pets.The increase in companion-animal healthcare spending by pet owners is expanding due to the growing perception of pets as family members, which drives owners to invest more in preventive care, advanced treatments, and overall well-being.The rising demand for companion-animal healthcare spending by pet owners drives the adoption of veterinary orodispersible tablets, as these convenient and palatable formulations improve compliance, ensure accurate dosing, and support the growing focus on pet wellness and preventive care.For instance, in March 2025, according to the American Pet Products Association (APPA), a US-based trade association for the pet industry, total US pet industry expenditures reached $147 billion in 2023, rising further to $152 billion in 2024, reflecting continued year-over-year growth.Therefore, expanding companion-animal healthcare spending by pet owners is driving the growth of the veterinary orodispersible tablets industry. The rising pet ownership globally is expected to propel the growth of the veterinary orodispersible tablets industry going forward.Pet ownership globally refers to the proportion of households worldwide that keep companion animals, reflecting the prevalence and cultural adoption of pets across different regions.The increasing pet ownership globally is rising due to the growing trend of viewing pets as family members, which motivates individuals and households to adopt companion animals for companionship, emotional support, and lifestyle enrichment.The rising global pet ownership drives demand for veterinary orodispersible tablets, as a larger companion-animal population increases the need for convenient, palatable, and easily administered medications to ensure health, compliance, and overall well-being.For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, currently, 94 million households in the U.S.own at least one pet, marking an increase from 82 million households in 2023.Therefore, rising pet ownership globally is driving the growth of the veterinary orodispersible tablets industry. The expansion of veterinary healthcare infrastructure is expected to propel the growth of the veterinary orodispersible tablets industry going forward.Veterinary healthcare infrastructure refers to the network of facilities, trained professionals, and medical resources dedicated to diagnosing, treating, and managing animal health.The growing development of veterinary infrastructure is largely driven by the rising rate of pet ownership, as more households across developed nations adopt companion animals, increasing the need for accessible and well-equipped veterinary care facilities.The expansion of veterinary healthcare infrastructure directly increases demand for advanced and easy-to-administer pharmaceutical dosage forms suited for animals of varying sizes and conditions.For instance, in December 2023, according to the American Veterinary Medical Association (AVMA), a US-based professional organization, the total number of veterinarians in the United States increased from approximately 124,069 in 2022 to approximately 127,131 in 2023, reflecting a rise of over 3,000 professionals within a single year.Therefore, the expansion of veterinary healthcare infrastructure is driving the growth of the veterinary orodispersible tablets industry.

Key Players In The Global Veterinary Orodispersible Tablets Market

Major companies operating in the veterinary orodispersible tablets market are Zoetis Inc., Elanco Animal Health Incorporated, Ceva Santé Animale S. A., Merck & Co. Inc., Virbac S. A., Phibro Animal Health Corporation, HIPRA S. A., Vetoquinol S. A., Norbrook Laboratories Limited, KRKA d. d. Novo mesto, Intas Pharmaceuticals Limited, Boehringer Ingelheim Animal Health GmbH, Hester Biosciences Limited, Huvepharma EOOD, AdvaCare Pharma, ODT Pharmaceuticals Inc., Provet Pharma Private Limited, Kyoritsu Seiyaku Corporation, Ani Healthcare Private Limited, Vee Remedies Private Limited, Skyec Drugs and Pharmaceuticals Private Limited, Dotcom Pharma Private Limited, Alicanto Vetcare Private Limited, Vetraise Remedies Private Limited, Vetson Healthcare Private Limited

Regional Insights

North America was the largest region in the veterinary orodispersible tablets market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Veterinary Orodispersible Tablets Market?

The veterinary orodispersible tablets market consists of sales of anti-inflammatory tablets, anti-seizure tablets, anti-diabetic tablets, anti-allergic tablets, gastroprotective tablets, antibiotic tablets, cardiovascular support tablets, respiratory support tablets, and immune support tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

What is the Market Assessment and Strategic Outlook for the Veterinary Orodispersible Tablets Industry?

The veterinary orodispersible tablets market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary orodispersible tablets industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

What is the Market Assessment and Strategic Outlook for the Veterinary Orodispersible Tablets Market Report 2026?

The veterinary orodispersible tablets market research report is one of a series of new reports from The Business Research Company that provides veterinary orodispersible tablets market statistics, including veterinary orodispersible tablets industry global market size, regional shares, competitors with a veterinary orodispersible tablets market share, detailed veterinary orodispersible tablets market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary orodispersible tablets industry. This veterinary orodispersible tablets market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.